| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.04 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.23 | 0.05 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.05 |